Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (381-390 of 636) with videos related to

Pageof 64
Sort By:
European Radiology|December 2, 2021
Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver diseaseYingzhen N Zhang, Kathryn J Fowler, Andrew S Boehringer, et al.
Radiology. Artificial Intelligence|June 26, 2020
Automated CT and MRI Liver Segmentation and Biometry Using a Generalized Convolutional Neural NetworkKang Wang, Adrija Mamidipalli, Tara Retson, et al.
JAMA|March 19, 2024
Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical TrialTracey G Simon, Robert M Wilechansky, Stefania Stoyanova, et al.
Alimentary Pharmacology & Therapeutics|September 18, 2023
Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitisNaim Alkhouri, Donald Lazas, Rohit Loomba, et al.
The American Journal of Gastroenterology|March 31, 2025
Association of Components of Metabolic Syndrome and the Progression of Nonalcoholic Fatty Liver DiseasePhuc Le, Moosa Tatar, Michael B Rothberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2020
Exercise Training Reverses Gut Dysbiosis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis: A Proof of Concept StudyAlexa Hughes, Jessica Dahmus, Gloriany Rivas, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 1, 2019
Intestinal iNKT cells migrate to liver and contribute to hepatocyte apoptosis during alcoholic liver diseaseKuei-Chuan Lee, Peng Chen, Igor Maricic, et al.
Hepatology (Baltimore, Md.)|April 23, 2024
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver diseaseNaga Chalasani, Eduardo Vilar-Gomez, Rohit Loomba, et al.
Journal of Hepatology|May 7, 2016
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trialJeffrey Cui, Len Philo, Phirum Nguyen, et al.
Hepatology (Baltimore, Md.)|January 17, 2020
Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR StudyVlad Ratziu, Arun Sanyal, Stephen A Harrison, et al.
Pageof 64

Showing results (381-390 of 636) with videos related to

Sort By:
Pageof 64
European Radiology|December 2, 2021
Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver diseaseYingzhen N Zhang, Kathryn J Fowler, Andrew S Boehringer, et al.
Radiology. Artificial Intelligence|June 26, 2020
Automated CT and MRI Liver Segmentation and Biometry Using a Generalized Convolutional Neural NetworkKang Wang, Adrija Mamidipalli, Tara Retson, et al.
JAMA|March 19, 2024
Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical TrialTracey G Simon, Robert M Wilechansky, Stefania Stoyanova, et al.
Alimentary Pharmacology & Therapeutics|September 18, 2023
Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitisNaim Alkhouri, Donald Lazas, Rohit Loomba, et al.
The American Journal of Gastroenterology|March 31, 2025
Association of Components of Metabolic Syndrome and the Progression of Nonalcoholic Fatty Liver DiseasePhuc Le, Moosa Tatar, Michael B Rothberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2020
Exercise Training Reverses Gut Dysbiosis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis: A Proof of Concept StudyAlexa Hughes, Jessica Dahmus, Gloriany Rivas, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 1, 2019
Intestinal iNKT cells migrate to liver and contribute to hepatocyte apoptosis during alcoholic liver diseaseKuei-Chuan Lee, Peng Chen, Igor Maricic, et al.
Hepatology (Baltimore, Md.)|April 23, 2024
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver diseaseNaga Chalasani, Eduardo Vilar-Gomez, Rohit Loomba, et al.
Journal of Hepatology|May 7, 2016
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trialJeffrey Cui, Len Philo, Phirum Nguyen, et al.
Hepatology (Baltimore, Md.)|January 17, 2020
Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR StudyVlad Ratziu, Arun Sanyal, Stephen A Harrison, et al.
Pageof 64